Navigation Links
InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery
Date:12/4/2009

InhibOx, a leading developer of novel and effective computational methods for drug discovery, has joined forces with MolPort, an innovator in rare chemical trading. MolPort focuses on developing rare chemical trading platform and builds database of commercially available compounds. Now we provide this database and its updates to computational chemists at InhibOx where they incorporate it into the virtual screening procedures. Once they identify suitable lead candidates, MolPort offers to efficiently source these compounds and deliver to the client for testing.

(PRWEB) December 4, 2009 -- InhibOx Ltd (Oxford, UK) and MolPort Ltd (Riga, Latvia) announce a strategic partnership to deliver integration in library design and compound provision.

InhibOx, a leader in drug lead identification and library design software and service, uses breakthrough proprietary technology to offer an on-demand virtual screening capability which has demonstrated dramatically improved results over traditional high throughput screening methods. The company has partnered with MolPort, the innovative compound provision consolidator/specialist.

Together, the two companies are able to provide a new, unique service which delivers novel lead candidates in the form of a rich data set and high quality compound samples. Frequently virtual screening identifies compound sets for testing which must be sourced from multiple suppliers, imposing a logistical problem, especially for smaller companies. This integrated service removes these bottlenecks, allowing much improved access to commercially available molecules.

Dr. Paul Finn, CEO of InhibOx, sees this as an important breakthrough in outsourced screening services. “InhibOx goes further than anyone else in value-added virtual screening, and the results bear this out. By adding library sample provision to the service, through MolPort’s highly responsive capability, we offer a unique integrated service which accelerates lead design and lowers the management costs for all customers”.

“Our goal is to make chemical buying as simple as buying a book on Amazon. Screening compound sourcing can be especially complex as it often involves locating suppliers for a large number niche products form companies all around the world. Integrating our database of commercially available compounds with InhibOx virtual screening processes enables streamlining of the road from idea to testable compounds in the clients laboratory. Partnering with InhibOx has allowed us to tailor our services for the needs of computational chemists.” said Dr. Imants Zudans, CEO of MolPort.

About InhibOx:

InhibOx develops novel and effective computational methods for drug discovery to improve the productivity of lead and candidate identification. The company was founded by Professor W. Graham Richards, former Chairman of Chemistry at the University of Oxford and world leading computational chemist. The company grew from the outstandingly successful Screensaver Lifesaver project which involved some 3.5 million personal computers in over 200 countries: the world's biggest computational chemistry experiment finding lead compounds to inhibit cancer targets, anthrax and smallpox. Since then, InhibOx has built up a significant technology platform in computer-aided drug design. Ongoing activities comprise the development of entirely novel computational drug discovery methods; the development of Scopius, a very large and carefully curated database of commercially-available and virtual chemical structures and their delivery to the life science industries.

About MolPort:

MolPort is a rare chemical compound marketplace enabling worry free centralized ordering of chemicals from over 200 companies. To make the marketplace work MolPort has created a world class database of commercially available chemical compounds. The free access online search portal www.molport.com features unmatched advanced chemical structure search capabilities that are especially suited for a sophisticated and demanding user.

# # #

Read the full story at http://www.prweb.com/releases/2009/12/prweb3298024.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. St. Jude Patients and Expert Chefs Join Forces To Create Gingerbread House
2. LeapFish and Make-a-Wish Foundation Join Forces to Raise $10,000 and Tweet an Ill Child's Wish True
3. Big Brothers Big Sisters Military Mentor Featured in New Civic Enterprises Report on Leadership and Our Armed Forces
4. Drug industry, nonprofits join forces to fight worlds neglected diseases
5. U.S. Army Special Forces Operators Reluctant to Seek Treatment for Posttraumatic Stress Disorder
6. Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care Delivery System
7. MTD Joins Forces with the AHA to Promote Heart Health
8. Cardinal Health Foundation, The Ohio State University College of Pharmacy Join Forces to Prevent Prescription Medication Abuse
9. Engineering center to probe forces that cause cancer to spread
10. Substance Abuse Expert Dr. Drew Joins Forces with the Five Moms to Raise Awareness About OTC Cough Medicine Abuse Among Teens
11. Ford and Labor Leaders Join Forces with March of Dimes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 
(Date:2/10/2016)... TX (PRWEB) , ... February 10, 2016 , ... ... commencement of a master charity program created to assist the local community. Pledging ... with community leaders and nonprofit organizations in the area. Their goal is to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Peyman Ghasri, ... now offering a variety of comprehensive procedures for facial enhancement. The treatments now ... restoration, lip enhancement and nasal reshaping. , As a result, patients can ...
(Date:2/10/2016)... St. Louis, Missouri (PRWEB) , ... February 10, ... ... 11-14, 2016, in San Diego, will bring together more than 200 of the ... in healthcare for the future. , “The true benefit of the Forum is ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... to effectively measure change in their patients. Research shows that the Goal Attainment ... To help therapists overcome this challenge and learn more about the Goal Attainment ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  CVS Health (NYSE: ... living in Santa Clara County, CA ... on the Santa Clara University campus. CVS Pharmacy stores ... protect patients against the disease. Students at Santa Clara ... get vaccinated. In addition, anyone who has had close ...
(Date:2/10/2016)... LOS ANGELES , Feb. 10, 2016  Oxis ... blood cancer drug, OXS-1550, was described as a "clinical ... with the drug went into complete cancer remission. ... the University of Minnesota Masonic Cancer Center. ... the University of Minnesota Masonic Cancer Center. ...
(Date:2/10/2016)... Feb. 10, 2016  LexisNexis® Risk Solutions, a ... announced the launch of LexisNexis Provider Performance ... helps improve and optimize the quality and efficiency ... using severity-adjusted scores. By measuring provider performance through ... to deliver better outcomes, improve the patient experience ...
Breaking Medicine Technology: